A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
The Biden administration's first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry's price negotiators is backfiring, pharmacists say.
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to
Biden Administration s Limit on Drug Industry Middlemen Backfires, Pharmacists Say healthleadersmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthleadersmedia.com Daily Mail and Mail on Sunday newspapers.